Astellas Cuts German Investment

Japanese drugmaker Astellas has announced that it is to cutback it operations in Germany becoming the latest sector player to disinvest in the country. Germany currently places third in BMI 's business Environment matrix for the Western European region but further divestments could result in a fall in the rankings.

To read the full article, please choose one of the following options: